Clinical Trial Update: Topical Fibrinogen-Depleted Human Platelet Lysate in Patients With Dry Eye Secondary to Graft vs. Host Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating topical fibrinogen-depleted human platelet lysate for dry eye caused by graft-versus-host disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye
• Graft-versus-host Disease

Drugs mentioned

• Topical fibrinogen-depleted human platelet lysate

Snippet

Sponsor: Cambium Bio Limited | Conditions: Dry Eye, Graft-versus-host-disease | Phase 1, Phase 2 | Status: COMPLETED